Literature DB >> 17721704

Is the brain biopsy obligatory or not for the diagnosis of Schilder's disease? Review of the literature.

Yuksel Yilmaz1, Canan Kocaman, Hakan Karabagli, Memet Ozek.   

Abstract

BACKGROUND: Schilder's myelinoclastic diffuse sclerosis (Schilder's disease) is a rare demyelinating disorder. Clinical features and neuroimaging findings of this disease might mimic an intra-cranial mass lesion including an abscess or a tumour. CASE REPORT: Clinical and radiological findings of two children with the diagnosis of Shilder's disease are reported, and the role of brain biopsy as a diagnostic tool is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721704     DOI: 10.1007/s00381-007-0411-9

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  13 in total

1.  Acquired inflammatory white matter disease.

Authors:  M Gallucci; M Caulo; G Cerone; C Masciocchi
Journal:  Childs Nerv Syst       Date:  2001-04       Impact factor: 1.475

2.  Stereotactic computed tomography-guided brain biopsy: diagnostic yield based on a series of 170 patients.

Authors:  Marcelo Paglioli Ferreira; Nelson Pires Ferreira; Arthur de Azambuja Pereira Filho; Gustavo de Azambuja Pereira Filho; André Cerutti Franciscatto
Journal:  Surg Neurol       Date:  2006

3.  Acute focal demyelinating disease simulating brain tumors: histopathologic guidelines for an accurate diagnosis.

Authors:  Y Sugita; M Terasaki; M Shigemori; K Sakata; M Morimatsu
Journal:  Neuropathology       Date:  2001-03       Impact factor: 1.906

4.  An analysis of stereotactic biopsy of brain tumors and nonneoplastic lesions: a prospective clinicopathologic study.

Authors:  Aylin Okcu Heper; Esra Erden; Ali Savas; Koray Ceyhan; Ilhan Erden; Serdar Akyar; Yücel Kanpolat
Journal:  Surg Neurol       Date:  2005

Review 5.  Pitfalls in the diagnosis of brain tumours.

Authors:  Antonio Mp Omuro; Claudia C Leite; Karima Mokhtari; Jean-Yves Delattre
Journal:  Lancet Neurol       Date:  2006-11       Impact factor: 44.182

6.  Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases.

Authors:  Matthew J McGirt; Graeme F Woodworth; Alex L Coon; James M Frazier; Eric Amundson; Ira Garonzik; Alessandro Olivi; Jon D Weingart
Journal:  J Neurosurg       Date:  2005-05       Impact factor: 5.115

7.  [Schilder's diffuse myelinoclastic sclerosis].

Authors:  A Fernández-Jaén; A Martínez-Bermejo; M Gutiérrez-Molina; V López-Martín; A Tendero; J Arcas; C Roche; I Pascual-Castroviejo
Journal:  Rev Neurol       Date:  2001 Jul 1-15       Impact factor: 0.870

8.  Schilder's disease: case study with serial neuroimaging.

Authors:  Semra Kurul; Handan Cakmakçi; Eray Dirik; Arzu Kovanlikaya
Journal:  J Child Neurol       Date:  2003-01       Impact factor: 1.987

9.  Frame-based stereotactic biopsy remains an important diagnostic tool with distinct advantages over frameless stereotactic biopsy.

Authors:  Justin S Smith; Alfredo Quiñones-Hinojosa; Nicholas M Barbaro; Michael W McDermott
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

10.  Schilder's myelinoclastic diffuse sclerosis.

Authors:  C M Poser; F Goutières; M A Carpentier; J Aicardi
Journal:  Pediatrics       Date:  1986-01       Impact factor: 7.124

View more
  2 in total

Review 1.  Schilder's disease: non-invasive diagnosis? :A case report and review.

Authors:  Susanna Bacigaluppi; Gabriele Polonara; Mario L Zavanone; Rolando Campanella; Vincenzo Branca; Sergio M Gaini; Giovanni Tredici; Antonella Costa
Journal:  Neurol Sci       Date:  2009-07-17       Impact factor: 3.307

2.  Tumefactive Multiple Sclerosis Variants: Report of Two Cases of Schilder and Balo Diseases.

Authors:  Mahmoud Reza Ashrafi; Ali Reza Tavasoli; Houman Alizadeh; Javad Zare Noghabi; Nima Parvaneh
Journal:  Iran J Child Neurol       Date:  2017
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.